About
Charles River Laboratories (NYSE:CRL) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Charles River Highlights Effectiveness of VCGs in Toxicology
Apr 16 2026
Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call
Apr 9 2026
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association
Apr 9 2026
NSG Bio and Charles River Sign Memorandum of Understanding to Strengthen Support for Biotech Innovation in Singapore
Mar 11 2026
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit
Recent Videos

15-min VitroGel® Hydrogel Injection Protocol | TheWell Bioscience
Apr 21, 2026

CEO Jim Foster Reflects on his Remarkable 50 years at Charles River
Apr 21, 2026

Day 1 at #AACR26 — and we're just getting started | Booth #1941
Apr 21, 2026

【10년 생존 #194】 | A- | 화이자가 약을 만들면 이 회사는 가만히 수수료를 챙깁니다. 전 세계 동물 실험 1위 기업의 소름 돋는 해자
Apr 20, 2026
Financials
Revenue
$4.02 B
Market Cap
$8.56 B
EPS
-2.90
Translate